Athos Therapeutics develops AI-based precision therapeutics for autoimmune and chronic inflammatory diseases. Their platform integrates medicinal chemistry and systems biology through machine learning, enabling the identification and development of novel drugs.
Athos synthesizes small molecules that target key disease factors safely and helps improve treatment outcomes for patients with conditions like inflammatory bowel disease and cancer, offering a more personalized therapeutic solution.
